Wuxi Taxus Pharmaceutical Co., Ltd is a High-Tech pharmaceutical enterprise with GMP and DMF. We are specially engaged in anticancer APIs, such as Paclitaxel(DMF:25759), Docetaxel, Cabazitaxel, Oxaliplatin, Irinotecan, Decitabine, Allopurinol, Ramosetron, Granisetron, Praziquantel,10-DAB,side chains and other anticancer Intermediates, APIs and Injections. Also we doing Custom-Synthesis and Toll manufacturing. Paclitaxel and Oxaliplatin registered in India, Korea etc.
more >
Year of Establishment:
2004
Total Assets(USD):
choose not to disclose
Total Number of Staff:
150 to 199
Main Competitive Advantages:
Brandname,International Approvals/Standards,Experienced R&D Staff
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Manufacturer
R&D capacity:
Annual Turnover(USD):
choose not to disclose
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East
Other Competitive Advantages:
Patents and Copyrights: